Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-07-05T14:29:43.158Z Has data issue: false hasContentIssue false
  • English
  • Français

The Need for Surveillance for Antimicrobial Resistance

Published online by Cambridge University Press:  02 January 2015

Victor Lorian
Victor Lorian*
Affiliation:
Bronx-Lebanon Hospital Center, Bronx, New York
*
Department of Epidemiology and Infection Control, Bronx-Lebanon Hospital Center, 1650 Grand Concourse, Bronx, NY 10457
Get access Rights & Permissions [Opens in a new window]

Abstract

Currently, collection of bacterial susceptibility data is very incomplete; national or international susceptibility data simply do not exist. The large volume of scientific publications on this subject contributes to the perception that bacterial resistance to antimicrobials is extensive and growing. However, only a very few papers address the epidemiology of bacterial resistance. Those papers that do report quantitatively on this topic are from hospitals that are systematically different from hospitals that do not publish. No one can deny the existence and the importance of drug resistance, but the sensational reports from the media are grossly untrue. Multidrug-resistant bacteria affect an extremely small proportion of patients. Most antibiotics still are highly effective and cure the majority of infections. It is proposed that medical microbiology laboratories report their susceptibility data on eight common species that constitute 68.5% of all isolates. Such reports could be analyzed and published yearly.

Type
Readers' Forum
Information
Infection Control & Hospital Epidemiology , Volume 16 , Issue 11 , November 1995 , pp. 638 - 641
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Holzman, D. FDA seeking advice on antibiotic resistance surveillance. ASM News 1995;61:58–59.Google Scholar
2. Surveillance systems for antibacterial resistance: FDA access to antibacterial resistance sur veillance data and appropriate FDA responses. Rockville, MD: November 9-10, 1994.Google Scholar
3. McGowan, JE. Antibiotic-resistant bacteria and healthcare systems: four steps for effective response. Infect Control Hosp Epidemiol 1995;16(2):67–70.CrossRefGoogle ScholarPubMed
4. Edlin, BR, Tokars, JI, Grieco, MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326(23):1514–1521.Google Scholar
5. Frieden, TR, Munsiff, SS, Low, DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76–79.Google Scholar
6. Murray, BE. Can antibiotic resistance be controlled? N Engl J Med 1994;330:1229–1230.CrossRefGoogle ScholarPubMed
7. Atkinson, BA, Lorian, V. Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol 1984;20:791–796.CrossRefGoogle ScholarPubMed
8. Centers for Disease Control and Prevention. Emerging infectious diseases: prevalence of penicillin-resistant Streptococcus pneumoniae—Connecticut, 1992-1993. MMWR. 1994;43:216–217, 223.Google Scholar
9. Butler, JC, Breiman, RF, Facklam, RR, the Pneumococcal Working Group. Emergence of drug-resistant pneumococci in the United States. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; New Orleans, LA; October 17-20, 1993. Abstract 1182.Google Scholar
10. Jones, RN, Kehrberg, EN, Erwin, ME, Anderson, SC, and the Fluoroquinolone Resistance Sur veillance Group. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I: study on the threat of emerging resistances: real or perceived? Diagn Microbiol Infect Dis 1994;19:203–215.CrossRefGoogle ScholarPubMed
11. Chamberland, S, L'Ecuyer, J, Lessard, C, et al. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. Clin Infect Dis 1992;15:615–628.Google Scholar
12. Ballow, CH, Schentag, JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992;15:37S–42S.Google Scholar
13. Gaynes, RP, Culver, DH, The National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10–14.CrossRefGoogle Scholar
14. Gordon, S, Swenson, JM, Hill, BC, Pigott, NE, Facklam, RR, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373–2378.CrossRefGoogle ScholarPubMed
15. Cuchural, GJ Jr Snydman, DR, McDermott, L, et al. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. Clin Ther 1992;14:122–136.Google Scholar
16. Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.CrossRefGoogle ScholarPubMed
17. Livornese, LL, Dias, S, Samel, C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.Google Scholar
18. Layton, MC, Perez, M, Heald, P, Patterson, JE. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993;14:369–375.Google Scholar
19. The National Research Council. The Effects on Human Health of Subtherapeutic Use of Antimicrobials in Animal Feed. Washington, DC: National Academy Press; 1980.Google Scholar
20. The Institute of Medicine Committee on Human Health Risk Assessment of Using Subtherapeutic Antibiotics in Animal Feeds. Human Health Risks With the Subtherapeutic Use of Penicillin or Tetracyclines in Animal Feed. Washington, DC: National Academy Press; 1989.Google Scholar
21. Wiedeman, B, Atkinson, B. Species incidence and trends. In: Lorian, V, ed. Antibiotics in Laboratory Medicine. Baltimore, MD: Williams & Wilkins; 1991:962–1208.Google Scholar
22. New project launched to track antibiotic resistance. Am J Hosp Pharm 1994;51:2874.Google Scholar